Literature DB >> 15570735

Benign prostatic hyperplasia: now we can begin to tailor treatment.

Carl K Gjertson1, Konstantin Walmsley, Steven A Kaplan.   

Abstract

Our treatment strategies for benign prostatic hyperplasia (BPH) have changed, with new insights into the pathophysiology of the disease, new clinical trials, and surgical advances. We present an update on treatment options and a diagnostic and treatment algorithm for this condition.

Entities:  

Mesh:

Year:  2004        PMID: 15570735     DOI: 10.3949/ccjm.71.11.857

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  1 in total

1.  Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a downregulator of 5α-reductase activity pathways in prostatic epithelial cells.

Authors:  Agung Heru Karsono; Olivia Mayasari Tandrasasmita; Raymond R Tjandrawinata
Journal:  Cancer Manag Res       Date:  2014-06-06       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.